Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial

Kai-Michael Beeh, Karl Scheithe, Heike Schmutzler, Saskia Krüger

Open source

DOI
10.2147/copd.s427770
Published
2024-01
Container
International Journal of Chronic Obstructive Pulmonary Disease
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/copd.s427770,
  title = {Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial},
  author = {Kai-Michael Beeh and Karl Scheithe and Heike Schmutzler and Saskia Krüger},
  year = {2024},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  doi = {10.2147/copd.s427770},
  url = {https://doi.org/10.2147/copd.s427770}
}

RIS

TY  - JOUR
TI  - Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial
AU  - Kai-Michael Beeh
AU  - Karl Scheithe
AU  - Heike Schmutzler
AU  - Saskia Krüger
PY  - 2024
JO  - International Journal of Chronic Obstructive Pulmonary Disease
DO  - 10.2147/copd.s427770
UR  - https://doi.org/10.2147/copd.s427770
ER  - 

APA

Beeh, K., Scheithe, K., Schmutzler, H., & Krüger, S. (2024). Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s427770

Source records